10x Genomics (TXG) Misses Q2 EPS by 22c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to 10x Genomics (TXG) Misses Q2 EPS by 22c

10x Genomics Reports Second Quarter 2022 Financial Results

August 8, 2022 4:05 PM EDT

PLEASANTON, Calif., Aug. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June 30, 2022.

Recent Highlights

Revenue was $114.6 million for the second quarter, representing a 1% decrease over the corresponding period of 2021.Announced the breakthrough capability of single-cell analysis on FFPE samples with its recently launched Fixed RNA Profiling Kit.Began shipping Visium CytAssist, the company's first spatial instrument.Announced the hiring of Jim... More